UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Present results and future perspectives in optimizing chronic myeloid leukemia therapy

Haematologica (Roma), 2018-06, Vol.103 (6), p.928-930

2018

Volltextzugriff (PDF)

Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Journal of clinical oncology, 2008-01, Vol.26 (3), p.455-462

2008

Volltextzugriff (PDF)

Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study

Haematologica (Roma), 2022-02, Vol.107 (2), p.500-509

2022

Volltextzugriff (PDF)

Autophagy in blood cancers: biological role and therapeutic implications

Haematologica (Roma), 2013-09, Vol.98 (9), p.1335-1343

2013

Volltextzugriff (PDF)

Management of early stage chronic myeloid leukemia: state-of-the-art approach and future perspectives

Current cancer drug targets, 2013-09, Vol.13 (7), p.749-754

2013

Volltextzugriff (PDF)

What challenges remain in chronic myeloid leukemia research?

Haematologica (Roma), 2013-08, Vol.98 (8), p.1168-1172

2013

Volltextzugriff (PDF)

PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization

Hematological oncology, 2015-09, Vol.33 (3), p.125-132

2015

Volltextzugriff (PDF)

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

The New England journal of medicine, 2015-10, Vol.373 (18), p.1733-1747

2015

Volltextzugriff (PDF)

Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review

Current diabetes reviews, 2010-07, Vol.6 (4), p.215-221

2010

Volltextzugriff (PDF)

Autografting Followed by Nonmyeloablative Immunosuppressive Chemotherapy and Allogeneic Peripheral-Blood Hematopoietic Stem-Cell Transplantation as Treatment of Resistant Hodgkin’s Disease and Non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2000-12, Vol.18 (23), p.3918-3924

2000

Volltextzugriff (PDF)

Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia

Blood, 2023-03, Vol.141 (13), p.1597-1609

2023

Volltextzugriff (PDF)

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

British journal of haematology, 2012-02, Vol.156 (3), p.346-353

2012

Volltextzugriff (PDF)

Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes

European journal of haematology, 2015-06, Vol.94 (6), p.463-463

Carella, Angelo M.

2015

Volltextzugriff (PDF)

Chronic myeloid leukemia: the basis of treatment for tomorrow

Haematologica (Roma), 2011-12, Vol.96 (12), p.1737-1739

2011

Volltextzugriff (PDF)

Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer

The Lancet (British edition), 2005-07, Vol.366 (9482), p.318-320

2005

Volltextzugriff (PDF)

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Annals of hematology, 2019-09, Vol.98 (9), p.2139-2150

2019

Volltextzugriff (PDF)

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

The Lancet (British edition), 2002-06, Vol.359 (9323), p.2065-2071

2002

Volltextzugriff (PDF)

Leukemia‐associated immunophenotypes subdivided in “categories of specificity” improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemia

Cytometry. Part B, Clinical cytometry, 2020-05, Vol.98 (3), p.216-225

2020

Volltextzugriff (PDF)

Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced‐stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi

British journal of haematology, 2015-05, Vol.169 (4), p.544-551

2015

Volltextzugriff (PDF)

Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study

British journal of haematology, 2014-03, Vol.164 (5), p.710

2014

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(186)
Mit Volltextzugriff
(150)

Publikationsform

Sprache

Englisch
(195)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(140)
Life Sciences & Biomedicine
(139)
Humans
(133)
Hematology
(99)
Female
(91)
Male
(90)
Middle Aged
(88)
Adult
(71)
Oncology
(54)
Aged
(53)
Biological And Medical Sciences
(50)
Medical Sciences
(50)
Adolescent
(35)
Treatment Outcome
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(33)
Transplantation, Autologous
(28)
Hematopoietic Stem Cell Transplantation
(26)
Hematologic And Hematopoietic Diseases
(23)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(23)
Aged, 80 And Over
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Present results and future perspectives in optimizing chronic myeloid leukemia therapy

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi

Autophagy in blood cancers: biological role and therapeutic implications

Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Management of early stage chronic myeloid leukemia: state-of-the-art approach and future perspectives

What challenges remain in chronic myeloid leukemia research?

PBSC mobilization in lymphoma patients: analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review

Autografting Followed by Nonmyeloablative Immunosuppressive Chemotherapy and Allogeneic Peripheral-Blood Hematopoietic Stem-Cell Transplantation as Treatment of Resistant Hodgkin’s Disease and Non-Hodgkin’s Lymphoma

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

Noncanonical β-catenin interactions promote leukemia-initiating activity in early T-cell acute lymphoblastic leukemia

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes

Chronic myeloid leukemia: the basis of treatment for tomorrow

Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

Leukemia‐associated immunophenotypes subdivided in “categories of specificity” improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemia

Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced‐stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi

Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study

Suchergebnisse filtern